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Lasso peptides are a diverse class of ribosomally synthesized and post-translationally modified peptides (RiPPs). Their 22 
proteolytic and thermal stability alongside their growing potential as therapeutics has increased attention to these 23 
antimicrobial peptides. With the advent of genome mining, the discovery of RiPPs allows for the accurate prediction of 24 
putatively encoded structures, however, MSn experiments only provide partial sequence confirmation, therefore 2D 25 
NMR experiments are necessary for characterisation. Multiple MS/MS techniques were applied to two structurally 26 
characterized lasso peptides, huascopeptin and leepeptin, and one uncharacterized lasso peptide, citrulassin C, which 27 
was not isolable in sufficient quantity for NMR analysis. We have shown that MS2 can be used to elucidate the full 28 
amino acid sequences previously predicted with genome mining for this compound class. HCD was able to open the 29 
macrocycles and fragment the newly opened linear peptides, confirming the complete amino acid sequences of the 30 
characterised lasso peptides. Additionally, to determine if this technique could be applied at the earliest stages of the 31 
isolation process, we targeted a lasso peptide found by genome mining, citrulassin C, and were able to fully elucidate 32 
the amino acid sequence using only MS2 from a semi-crude extract of Streptomyces huasconensis HST28T.  33 
 34 
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Lasso peptides are gaining increased attention due to their range of biological activities. Of the four classes of lasso 42 
peptides, class II is the largest and displays a wide variety of biological activities, including antimicrobial, anticancer and 43 
anti-HIV (1). Actinobacteria are the most prolific sources of antimicrobial lasso peptides making them ideal target 44 
organisms for the isolation of bioactive lasso peptides (2-12). Even though today between 70-80 lasso peptides have 45 
been described, bioinformatic tools like RODEO and RiPPER are showing that we have barely scratched the surface 46 
when it comes to appreciating their structural diversity (13-15). These tools, along with others like antiSMASH (16), 47 
have made it possible to predict a strain’s biosynthetic potential prior to any chemical experimentation, yet, these are 48 
just predictions which should not be mistaken for confirmation of a compound being produced. Tietz et al. showed the 49 
power of predicting lasso peptide biosynthetic gene clusters and subsequent confirmation using accurate mass and 50 
MS2, but with limitations in MSn to fragment lasso peptides, these are only partial sequence confirmations showing 51 
only fragmentation of the tail (15).  52 
 MSn experiments are an essential tool in cyclic peptide studies but have yet to be fully utilised when studying 53 
lasso peptides. Fragmentation of linear peptides is well defined by Peptide Fragmentation Pathways (PFPs) (17) but 54 
cyclic peptides tend to open randomly when fragmented (18), resulting in complex MSn spectra. This phenomenon 55 
plagues de novo peptide sequencing but has become more manageable with the introduction of bioinformatics and 56 
automated mass spectrometric data analysis approaches (19-23). However, putative structures of RiPPs can be 57 
predicted using genome mining, therefore, these complex spectra can be somewhat deconvoluted by known fragment 58 
ions produced in PFPs. The combination of genome mining and automated mass spectrometry identification 59 
culminated in RiPPquest (21), yet without ways to open the single or sometimes multiple cycles characteristic of RiPPs, 60 
sequence elucidation by mass spectrometry still requires further structure elucidation and confirmation via NMR based 61 
techniques.  62 
 Mass spectrometry has been the primary tool for evaluating production of lasso peptides in genome mining 63 
approaches as well as in studies involving heterologous expression, but limitations in MS2 due to the stable 64 
macrolactam ring has prevented mass spectrometry from becoming a definitive technique in the characterization of 65 
lasso peptides. Full structure characterisation of lasso peptides is a process reliant on 2D NMR experiments (1,24). In 66 
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both publications first describing the lasso topology of microcin J25, investigators utilized MS3 studies to fragment the 67 
macrocycle further. Although this did open the ring, it was still inefficient at completely breaking each amino acid bond, 68 
resulting in non-sequential fragments that would make de novo sequencing difficult (25,26). Recently, it was shown 69 
that MSn experiments using CID and ETD can provide topological information through a combination of identifying 70 
interlocked fragments and higher instances of hydrogen migration events, respectively, showing MSn can be a more 71 
powerful tool in lasso peptide characterisation (27). Additionally, a separate methodology was established using 72 
trapped ion mobility spectrometry – mass spectrometry (TIMS-MS) to efficiently and quickly differentiate lasso 73 
peptides from their unthreaded branched-cyclic topoisomers (28). Both studies show the expanded use of MSn for 74 
further structure characterisation of lasso peptides. 75 
In this study, MSn experiments were carried out on three lasso peptides, two previously characterized by mass 76 
spectrometry and NMR, and one detected in a semi-crude extract from Streptomyces huasconensis HST28T, confirming 77 
genome mining predictions. All lasso peptides and extracts originated from previous studies working with Atacama 78 
Desert Streptomyces spp. Collisional-induced dissociation (CID), electron-transfer dissociation (ETD), and higher energy 79 
collisional dissociation (HCD) for MS2 and electron-transfer/higher-energy collisional dissociation (EThcD) for MS3 were 80 
all carried out using stepped collision energies in order to see if one or more of the techniques would carry out 81 
macrocycle opening, leading to observable complete fragmentation of the lasso peptides. MS2 HCD was the only 82 
technique that provided enough information to confirm the entire amino acid sequence of all three lasso peptides test. 83 
 84 
RESULTS 85 
Fragmentation of huascopeptin 86 
The fragmentation of huascopeptin - Cyclo(GYGNAWD)-SKNGLF-, performed on the [M+2H]2+ ion (m/z 705.80), was 87 
initially evaluated using 35% CID. The resulting spectrum matches the previously reported MS2 spectra (29), showing 88 
sequential fragmentation of the tail and an ion for the macrocycle (m/z 746.28). ETchD showed some potential for 89 
opening the ring (Figure S1) but low ion counts were observed when compared to HCD. It was observed that HCD with 90 
23-25% relative collision energy (RCE) exhibited the optimal fragmentation of the macrolactam ring and the linear 91 
peptide. Huascopeptin’s macrocycle (GYGNAWD) was opened randomly, forming 7 linear peptides (Scheme 1). These 92 
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7 linear peptides yield a theoretical 42 b ions, out of which only 35 are observable due to the mass range cut-off. Out 93 
of these 35 ions, 33 were observed in addition to 27 out of 35 total a ions. The HCD spectrum of huascopeptin is 94 
displayed in Figure 1, along with the zoomed spectrum that displays the mass range for the macrocycle fragment ions. 95 
ETD/HCD showed some fragmentation of the ring (Figure S2), but significantly lower ion counts were observed for Trp6, 96 
the primary indicator in the low mass range that the ring is being opened for huascopeptin (Figure S2). A full table of 97 
observed fragment ions is available in Table S1. 98 
 Overall, there were three observable ring opening events that we can detect in the spectrum of huascopeptin. 99 
(1) Cleavage of the tail residues first and subsequent ring opening at random positions as shown in Scheme 1, (2) 100 
formation of a branched or “T-shaped” structure where the macrocycle opens in the middle and the tail remains intact 101 
(Figure 1), and (3) ring opening at the isopeptide bond first, leading to fragmentation of a linear peptide (Figure 2). 102 
While 1 and 3 are difficult to distinguish experimentally, ions resulting from option 2 are indeed observed, but in our 103 
experience are less favoured. 104 
 105 
Fragmentation of leepeptin 106 
Similar to huascopeptin, CID with 35 % RCE on the [M+2H]2+ ion (m/z 1170.02) of leepeptin, Cyclo(LYGVRNDE)-107 
EINWHFDYWT, showed results previously described with the tail being sequentially fragmented (30). Comparable 108 
fragmentation using the different techniques was observed for leepeptin as was observed for huascopeptin (Figure S3).  109 
 The same HCD conditions for huascopeptin were used and exhibited the optimal fragmentation of the 110 
macrolactam ring. The macrolactam ring (LYGVRNDE) fragments like other cyclic peptides, opening randomly at each 111 
peptide bond, causing eight linear peptides to form (Scheme S1). Previous CID fragmentation results showed the 112 
cleavage of Glu9 from the tail region and the intact macrocycle (m/z 946.46), leading to the conclusion that Leu1 and 113 
Glu8 form the macrocycle, which was backed further by 2D NMR results in a previous study (30) and our HCD results 114 
(Figure S4 and Figure S5) 115 
 Overall, HCD fragmentation exhibited enough energy to open the macrocycle of leepeptin while also leaving 116 
sufficient structural information to observe fragmentation of the tail (Figure S4). The macrocycle of leepeptin randomly 117 
opens at each amino acid linkage forming 8 linear peptides (Scheme S1). Of these 8 linear peptides, 56 total b ions are 118 
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possible. All b1 ions were not detected due to the mass range cut off at m/z 150, therefore a total of 48 b ions were 119 
theoretically predicted (Scheme S1). Of these, 25 were experimentally observed in the spectrum. For linear peptides 7 120 
and 8, no b ions were detected but a and y ions were present in the spectrum (Figure S5), which in some cases also 121 
prove to be diagnostic. However, this approach was complicated by separate fragmentation pathways yielding identical 122 
nominal masses for fragments. For instance, y2ED (m/z 230.0771) overlaps with b2NR (m/z 230.0771). Upon closer 123 
inspection, these two ions correspond for the same amino acid cleavage of Asn6-Asp7, therefore their overlap does 124 
not hinder spectral interpretation. A full table of observed fragment ions is available in Table S2. 125 
 126 
Complete amino acid sequence elucidation of citrulassin C 127 
At the time of running these pure compounds, we knew that the genome of Streptomyces huasconensis HST28T 128 
contained a gene cluster and core peptide for another lasso peptide, citrulassin C. In order to determine the capability 129 
of the method for determining lasso peptide amino acid sequences de novo, we attempted to elucidate the full amino 130 
acid sequence of this previously detected lasso peptide by Tietz et al (15). 131 
When the SPE fraction of the Streptomyces huasconensis HST28T crude extract was analysed by LCMS (Figure 132 
S6) we observed an [M+2H]2+ ion at m/z 855.4866, suggesting the presence of citrulassin C – Cyclo(LLQRSGND)-Cit-133 
LILSKN – , which was previously reported from the culture medium of Streptomyces albulus NRRL S-146 but never 134 
isolated for NMR analysis (15). We applied the LCMS protocol, with HCD fragmentation, as described above to confirm 135 
the sequence of amino acids directly to an SPE fraction of the crude extract that still displayed an ion count deemed 136 
sufficient for the ion of interest. HCD using 35-40% normalized collision energy was optimal for opening the macrocycle 137 
(Figure 3). As expected, lower ion counts were observed in the semi-crude extract than for the pure compounds, 138 
therefore, ions for the varying linear peptides generated during macrocycle opening were not observed. Nevertheless, 139 
sequence confirmation of citrulassin C was observed through the fragmentation of the putative genome-mined amino 140 
acid sequence.  141 
The b6 and its complimentary fragment ion, y9, were the only gap in the sequence but due to the unique mass 142 
loss of glycine, no other amino acid fits into this position. Based on the rules for lasso peptide macrocycles and the 143 
observed fragment ions of the linear peptide corresponding to the anticipated sequence (LLQRSGND), we show that 144 
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citrulassin C is the first lasso peptide to have its full amino acid sequence confirmed using only mass spectrometry. All 145 
observed fragments for citrulassin C are present in Table S3. 146 
 147 
DISCUSSION 148 
HCD fragmentation provided the only MS2 information that makes full sequence elucidation possible for huascopeptin 149 
and leepeptin. The results clearly demonstrate that HCD not only fragments the tail sequentially from the C-terminus 150 
but also is able to open the macrolactam ring and induce diagnostic fragmentation. In the case of citrulassin C, sequence 151 
elucidation was possible but confirmation of the resultant 8 linear peptides from fragmentation was not due to low 152 
quantity of this lasso peptide in semi-crude extract. Prior to this study, chemical cleavage or proteolytic digestion 153 
followed by MSn has been used to open only two lasso peptide macrocycles as the overwhelming majority of lasso 154 
peptides are resistant to both forms of degradation (1). Thermolysin digestion was used to open the macrocycle of 155 
streptomonomicin and using MALDI-TOF, the linear peptide sequence was partially elucidated (31). Chemical cleavage 156 
was used to open the benenodin-1 C5 macrocycle as well as other cyclic peptides and rotaxanes with subsequent 157 
MS/MS to determine the amino acid sequences (32), but this also required an additional step that MS2 HCD 158 
fragmentation does not require. Purification of the compounds also has been made an optional step in the process, 159 
although the results clearly show that purified compounds allow for increased observation of fragment ions.  160 
The normal complexity of random cyclic peptide fragmentation causes increased but manageable difficulty in 161 
spectral deconvolution as seen in Figures 1, 3 and S4. Similar to other RiPPs, lasso peptide biosynthetic gene clusters 162 
are well characterised and follow the standard motif of a leader and core peptide [11], therefore, putative structures 163 
of lasso peptides can predicted based on certain rules on ring size, isopeptide bond formation, and overall peptide size. 164 
However, bioinformatic prediction does not equate to confirmation, as biosynthetic gene clusters can be ‘silent’ or 165 
‘cryptic’ and as a consequence, potentially not expressed.  166 
The two fully characterized lasso peptides represent two structurally different variants of class II lasso peptides. 167 
Leepeptin (30) contains 18 amino acids including many aromatic tail residues and represents a very small percentage 168 
of lasso peptides that have a leucine at the N-terminus (15). Huascopeptin contains 13 residues and was the first lasso 169 
peptide with a seven-residue Gly-Asp macrocycle (29). Additionally, citrulassin C also consists of a leucine residue at 170 
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the N-terminus and the ring forming aspartic acid, with no aromatic amino acids. These three structurally different class 171 
II lasso peptides provide good evidence for the method being more widely applicable to class II lasso peptides. The 172 
study focused on class II lasso peptides only as they are the most well described, their chemical space is exponentially 173 
greater compared to other classes, and they represent the most biological relevant class of lasso peptides at the 174 
moment.  175 
HCD provided no topological information as far as we are able to interpret the spectra. No interlocked and/or 176 
hydrogen migration fragments were observed, nor would we expect them. These typically only occur in ‘softer’ 177 
fragmentation techniques like ETD or ECD but are not observable in HCD (33). All three HCD spectra include extra ions 178 
associated with internal fragmentation, common in HCD spectra, that were uninformative for the scope of this work 179 
(33). We see this advancement as a compliment to the CID/ETD technique previously described (27). Each technique 180 
fills the gaps left by the other (i.e., HCD opens the macrocycle where CID/ETD does not and CID/ETD allows for lasso 181 
topology of the lower plug to be determined, where HCD cannot). Overall, different fragmentation techniques and 182 
mass analysers are continually being explored for their potential use for characterising lasso peptides.  183 
Additionally, other MS/MS studies involving lasso peptides evaluate the branched-cyclic topoisomers but 184 
generating these were outside of the general scope of this project. In the aim to evaluate these fragmentation 185 
techniques as a means to open the macrocycles to confirm genomic predictions at the earliest stages of fermentation, 186 
the lasso topology is overwhelmingly the most relevant confirmation to study. Without the aid of mutasynthesis and 187 
alterations to biosynthetic gene clusters, only one lasso peptide, lassomycin, has ever been found with a branched-188 
cyclic topology outside of unthreading at elevated temperature (1). Studies have shown that when lasso peptides lose 189 
their lasso topology, they also lose their biological activity and their thermal stability, making it biologically extraneous 190 
to produce the branched-cyclic topology (1). This is reinforced by the fact that lasso peptide biosynthetic gene clusters 191 
that do not contain ABC transporters, contain isopeptidase enzymes responsible for breaking the macrocycle, removing 192 
the lasso topology and thus removing the biological activity (34).  193 
MS3 experiments seem to be unnecessary as we have shown MS2 is sufficient for observation of all relevant 194 
ions. Overall, mass spectrometry requires a fraction of the sample NMR requires for structural elucidation as well as no 195 
special sample preparation besides desalting and the removal of compounds harmful to mass spectrometers, allowing 196 
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for detection of lasso peptides in crude or semi-crude extracts and subsequent MS2 with HCD to fully elucidate the 197 
amino acid sequence. Additionally, early mass spectrometry-based analysis of lasso peptides and other RiPPs can 198 
inform about post-translational modifications which are typically difficult to predict with genome mining alone. A prime 199 
example of this are the citrulassins, which were initially determined by MS2 to contain a citrulline post translational 200 
modification in the tail residues (15). The methodology described here unlocks the further potential of detecting post 201 
translational modifications within the macrocycle. 202 
The producing strains, Streptomyces leeuwenhoekii C34T (35)  and Streptomyces huasconensis (36) both 203 
originate from Atacama Desert high-altitude salt flats, Salar de Atacama and Salar de Huasco, respectively, that are 204 
seasonally covered in water. The extreme environments these isolates arise from have been shown to contain a rich 205 
biodiversity in actinomycetes (35,37-39) as well as rich in secondary metabolites (8,37,38,40). The interface of the 206 
extremes from the desert biosphere (i.e., high UV radiation, high salinity gradients, high altitude) coupled to the marine 207 
environment, makes these bacteria a potentially interesting starting point for continuing drug discovery efforts. 208 
We have shown in this study, using the examples of leepeptin and huascopeptin, that full amino acid sequence 209 
elucidation of lasso peptides is possible using only MS2 without any prior sample preparation or proteolytic digestion. 210 
Additionally, confirmation of predicted amino acid sequences at the earliest stages of bacterial fermentation was 211 
shown using citrulassin C, adding to the growing use of mass spectrometry in lasso peptide studies. Using MS2 HCD 212 
fragmentation removes the need for NMR techniques for amino acid sequence confirmation of these RiPPs and 213 
increases the scope of mass spectrometric based analysis. With further development, HCD and CID/ETD could have the 214 
potential to fully elucidate lasso peptide sequences and lasso topology, respectively, rendering NMR as the 215 
complimentary technique and mass spectrometry the main technique for lasso peptide identification and 216 
characterisation. Additionally, lasso peptides represent a unique group of peptide antimicrobial compounds that show 217 
promise as potent and narrow spectrum antibiotics that are amenable to engineering as therapeutics. The ability to 218 
accurately predict putative structures using genome mining, the detection of lasso peptides in the crude extract stage 219 
and to subsequently be able to confirm their complete amino acid sequence makes this a major tool in the continued 220 





Leepeptin and huascopeptin were isolated in previous studies (29,30). A SPE fraction of the crude extract containing 224 
citrulassin C was obtained from large scale fermentation of Streptomyces huasconensis HST28T using the same 225 
conditions described for the isolation of huascopeptin. Nomenclature for the linear peptides formed via random ring 226 
opening during HCD follows the work of Ngoka and Gross (18). Use of this nomenclature system is shown in Figures 1 227 
and S1. Interpretation of lasso peptide fragmentation was aided by the use of ProteinProspector MS-Product 228 
(http://prospector.ucsf.edu). Linear cyclic peptides were input into this online fragmentation prediction software in 229 
order to determine all of the possible a, b, and y ions resulting from the opening of each lasso peptide macrocycle. 230 
 231 
Sample preparation and MSn acquisition 232 
Both leepeptin and huascopeptin (100 g each) were dissolved in 0.1% TFA to a final concentration of about 280 233 
pmol/µL. To improve solvation samples were vortexed, ultra-sonicated and stored overnight in a refrigerator (4 C). 234 
Subsequently, each sample was centrifuged, and an aliquot of the supernatant was diluted with a solution containing 235 
30% acetonitrile acidified with 0.1% formic acid. Finally, leepeptin and huascopeptin were measured by direct-infusion 236 
experiments on an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo Scientific) using a flex-source coupled 237 
with a 25 µL syringe and spray voltage was set to 1.8 kV. Four different fragmentation methods were attempted (CID, 238 
EThcD, HCD, HCD/ETD using 100 and 200 ms activation time for ETD). The precursor masses of m/z 705.8 239 
(huascopeptin) and m/z 1170.5 (leepeptin) were selected for all MS2 experiments. The resolution of the Orbitrap was 240 
fixed to 60,000 using an isolation width of 2 Da for all MSn experiments. The relative collision energy for HCD was 241 
manually varied between 15 to 25% and up to 35% for all MS3 experiments.  242 
The SPE fraction (2.5 mg) containing citrulassin C was dissolved in 1 mL of 10% acetonitrile acidified with 0.1% 243 
TFA After centrifugation, the supernatant was diluted 1/200 in 0.1% formic acid to give a final concentration of about 244 
12.5 ng/mL. 15 µL was injected into a nano-HPLC system (Ultimate 3000, Thermo Scientific) using a precolumn (Acclaim 245 
Pepmap, 100 µm  2 cm, Thermo Scientific) for pre-concentration and an Acclaim Pepmap 100 C18 column (3 µm, 75 246 
µm  50 cm) for separation. The gradient used was: 30 min from 3% to 50% of eluent B (eluent A: aqueous 0.1% formic 247 
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acid, eluent B: 84% acetonitrile/ aqueous 0.1% formic acid). The nano LC system was coupled to an LTQ Orbitrap Velos 248 
Pro mass spectrometer (Thermo Scientific) for detection. HCD was used for fragmentation using a Top 5 method. 249 
Different normalized collision energy settings were used in each run (CE 25/30/35/40). With respect to the long cycle 250 
time of this instrument, the mass resolution for MS1 was set to 30,000 and to 7,500 for MS2. The spray voltage applied 251 
to the PicoTip emitter (New Objective) was set to 1.5 kV. 252 
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FIGURE LEGENDS 352 
 353 
Scheme 1. Sequence of b ions from the fragmentation of the macrolactam ring of huascopeptin. According to 354 
conventions of cyclic peptide fragmentation, random ring opening events occur yielding 7 linear peptides. C terminus 355 
cleavages occur sequentially, yielding 35 b ions. All b1 ions are below the m/z threshold of 150 and therefore are not 356 
considered for this study. 357 
 358 
Figure 1. (Top) MS2 spectrum of huascopeptin fragmented with HCD at 25% RCE. (Bottom) MS2 spectrum of 359 
huascopeptin macrolactam ring linear peptide 1 (see Scheme S1). Presence of a and b ions is indicated in the spectrum. 360 
Additionally, linear peptide spectra can be found in Figures S2. 361 
 362 
Figure 2. MS2 spectrum of huascopeptin: Evidence for branched or “T-shaped” fragments. Opening first occurs at a 363 
peptide bond within a macrocycle followed by subsequent cleavage of macrocycle residues. 364 
 365 
















Figure 3. 374 
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